Viona Pharmaceuticals Inc.

Zydus Lifesciences Secures FDA Approval for Generic Ammonium Lactate Cream for Dry Skin Conditions

- Zydus Lifesciences received final FDA approval for Ammonium Lactate Cream 12%, a generic version of Lac-Hydrin Cream for treating xerosis and ichthyosis vulgaris. - The topical prescription medication functions as both a moisturizer and alpha-hydroxy acid to increase skin hydration, relieve itching, and reduce scaling. - The approved product targets a market with annual sales of $15 million in the United States, expanding Zydus's dermatology portfolio to 430 total FDA approvals.